Advair Diskus · DIN 02240837 · 50/500 mcg · inhaler, 60 doses
Limited Use, Reason for Use code 330 requiredMarketed · checked October 5, 2026
StatusLimited Use, Reason for Use code 330 required
Write on scriptReason for Use code 330 (criteria below)
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 330
Reason for Use code 330
For the treatment of asthma in patients who are using optimum anti-inflammatory treatment and are still experiencing breakthrough symptoms.
Coverage limit:
LU Authorization Period: Indefinite
Savings card: innoviCares lists Advair Diskus (Ontario list dated 2026-09-10) — pays part of the brand-versus-generic difference after other coverage; free sign-up. (innovicares.ca ↗)
1 brand, same coverage
Advair Diskus · DIN 02240837
Manufacturer: GlaxoSmithKline Inc., GlaxoSmithKline Consumer Health Care; listing date 2000-07-17
Health Canada: Marketed since 2002-03-08 · brand ADVAIR 500 DISKUS · ATC R03AK06 SALMETEROL AND FLUTICASONE · form Powder · route Inhalation · ingredients FLUTICASONE PROPIONATE 500 MCG/ACT, SALMETEROL (SALMETEROL XINAFOATE) 50 MCG/ACT · company Glaxosmithkline inc · schedule Prescription
Ministry pays: $72.0600 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02240837)
Source record
DIN 02240837: Advair Diskus
Raw flags: sec12=Y, sec3=Y
Item: 121200081; group id 237; item number 0423; lccId 00044; manufacturer id GSK
Source form: Inh-60 Dose Pk; strength: 50/500mcg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $196.5400; ministry $72.0600
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02240837
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=64428
Interchangeable products
PMS-FluticasonePropionateSalmeterol DPI · DIN 02494523 · $72.0600
Wixela Inhub · DIN 02495619 · $72.0600
Shortage status: resolved shortage (ended April 18, 2023); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02240837
Shortage record checked October 6, 2026